NHS weight-loss drug

A new non-hormonal drug has been approved to treat menopausal hot flushes. It works by regulating the body's cooling signals and is now available on the NHS in England for those who cannot use hormone replacement therapy. Before delving into the evidence with resident GP Dr Marga ...  Afficher plus

Little over a week on from the first meningitis cases in Canterbury, many crucial questions remain. So this week we're taking an in-depth look at those questions and what we’ve learnt from this outbreak - and could it happen again?James also hears from author Michael Rosen whose ...  Afficher plus

Anti-obesity jabs like Ozempic could reduce the risk of heart attacks, strokes or heart failure in obese people regardless of the amount of weight they lose while on the drug.   
  
Researchers found after three years of treatment participants had a 20% lower risk of ob ...  Afficher plus

It’s become a multibillion-dollar business: weight loss drugs. Demand is high, as is the cost. How did medications like Ozempic, Wegovy, Mounjaro and Zepbound become so popular and so profitable? And what kind of impact might they have on the future of food and healthcare? Dr. Sa ...  Afficher plus

In today's episode of the podcast, I interview Dr. Rocio Salas-Whalen, owner of New York Endocrinology on Park Avenue. Dr. Salas-Whalen has deep expertise in diabetes, metabolism, obesity, thyroid abnormalities and other endocrine disorders. She completed her internal medicine re ...  Afficher plus

Pharmaceutical companies and insurance providers are at odds over a new class of drugs that have proven quite effective at helping people living with obesity lose weight. Bloomberg’s Robert Langreth and Emma Court join this episode to share their reporting on recent advancements ...  Afficher plus